Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-21: A Key Small Molecule with Great Effects in Combination Cancer Therapy
Nahid Arghiani, Maryam Moghaddam Matin
Nucleic Acid Therapeutics (2021) Vol. 31, Iss. 4, pp. 271-283
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Next-Generation Sequencing Technology: Current Trends and Advancements
Heena Satam, Kandarp Joshi, Upasana Mangrolia, et al.
Biology (2023) Vol. 12, Iss. 7, pp. 997-997
Open Access | Times Cited: 404
MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology
Himmat Singh Chawra, Mohit Agarwal, Anurag Mishra, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155091-155091
Closed Access | Times Cited: 14
Enhanced theranostic efficacy of epirubicin-loaded SPION@MSN through co-delivery of an anti-miR-21-expressing plasmid and ZIF-8 hybridization to target colon adenocarcinoma
Amir Abrishami, Ahmad Reza Bahrami, Amir Sh. Saljooghi, et al.
Nanoscale (2024) Vol. 16, Iss. 12, pp. 6215-6240
Closed Access | Times Cited: 12
ENTPD8 Overexpression Enhances Anti-PD-L1 Therapy in Hepatocellular Carcinoma via miR-214-5p Inhibition
Siqi Zhao, Minjie Chen, Fei Chen, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111819-111819
Open Access
miR-21 promotes cervical cancer by regulating NTF3
Yishan Chen, Caiwu Su, Yong Cai, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Harnessing Pseudogenes for Lung Cancer: A Novel Epigenetic Target in Diagnosis, Prognosis and Treatment
Yock Young Dan, Xinyi Zhao, Jing Li, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 208, pp. 104645-104645
Closed Access
Modulating microRNAs in cancer: Next-generation therapies
Nahid Arghiani, Khalid Shah
Cancer Biology and Medicine (2021), pp. 1-1
Open Access | Times Cited: 32
Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus
Ursula Heilmeier, Matthias Hackl, Fabian Schroeder, et al.
Bone (2022) Vol. 158, pp. 116308-116308
Open Access | Times Cited: 19
Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer
Tara Akhtarkhavari, Ahmad Reza Bahrami, Maryam Moghaddam Matin
European Journal of Pharmacology (2022) Vol. 932, pp. 175233-175233
Closed Access | Times Cited: 18
The Multifaceted Role of miR-21 in Pancreatic Cancers
Clare Chen, Lusine Demirkhanyan, Christopher S. Gondi
Cells (2024) Vol. 13, Iss. 11, pp. 948-948
Open Access | Times Cited: 3
Exosome-Mediated Response to Cancer Therapy: Modulation of Epigenetic Machinery
Mohammad Imran Khan, Reem Khaled M.E. Alsayed, Hani Choudhry, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6222-6222
Open Access | Times Cited: 16
MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway
Tongtong Li, Jie Mou, Yao‐Jie Pan, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 22
Noncoding RNAs Emerging as Drugs or Drug Targets: Their Chemical Modification, Bio-Conjugation and Intracellular Regulation
Jin Wang, Tian Tian, Xin Li, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6717-6717
Open Access | Times Cited: 15
Identifying miRNA biomarkers for breast cancer and ovarian cancer: a text mining perspective
Xin Li, Andrea Dai, Richard Tran, et al.
Breast Cancer Research and Treatment (2023) Vol. 201, Iss. 1, pp. 5-14
Closed Access | Times Cited: 8
MiR-103a-3p Promotes Tumorigenesis of Breast Cancer by Targeting ETNK1
Lei Li, Aifeng Qiu, Yuhua Shi
Iranian Journal of Public Health (2024)
Open Access | Times Cited: 2
The impact of microRNAs on the resistance of breast cancer subtypes to chemotherapy
Amir Ebrahimi, Peyman Bakhshaei Shahrebabaki, Hadi Fouladi, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154702-154702
Closed Access | Times Cited: 7
MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related Processes
Cyril Sobolewski, Laurent Dubuquoy, Noémie Legrand
Cancers (2022) Vol. 14, Iss. 14, pp. 3516-3516
Open Access | Times Cited: 11
microRNAs: Small molecules with a large impact on colorectal cancer
Sahand Moazzendizaji, А В Севбитов, Fatemeh Ezzatifar, et al.
Biotechnology and Applied Biochemistry (2021) Vol. 69, Iss. 5, pp. 1893-1908
Closed Access | Times Cited: 15
Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy
С. К. Мирошниченко, Olga Patutina, Aleksandra V. Sen’kova, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4396-4396
Open Access | Times Cited: 10
EV-mediated intercellular communication in acute myeloid leukemia: Transport of genetic materials in the bone marrow microenvironment
Qi Zhou, Zijian Li, Yaming Xi
Experimental Hematology (2024) Vol. 133, pp. 104175-104175
Closed Access | Times Cited: 1
Lnc NBAT1 Inhibits the Proliferation and Migration of Liver Cancer Cells Through the miR-21/PDCD4/AP-1 Signaling Axis
Hongyan Zai, Xinyu Wu, Yi-Fan Zhou, et al.
Applied Biochemistry and Biotechnology (2024)
Closed Access | Times Cited: 1
miRNA interplay: Mechanisms and therapeutic interventions in cancer
Zehua Wang, Hongwei Wang, Shuhan Zhou, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 1
Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155
Hongbo Qian, Mazaher Maghsoudloo, Parham Jabbarzadeh Kaboli, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 14, pp. 2781-2798
Open Access | Times Cited: 1
Gastric cancer and mesenchymal stem cell-derived exosomes: from pro-tumorigenic effects to anti-cancer vehicles
Maryam Dolatshahi, Ahmad Reza Bahrami, Qaiser I. Sheikh, et al.
Archives of Pharmacal Research (2023) Vol. 47, Iss. 1, pp. 1-19
Closed Access | Times Cited: 4
Upregulated MicroRNA-21 Drives the Proliferation of Lymphatic Malformation Endothelial Cells by Inhibiting PDCD4
Ravi W. Sun, Haihong Zhang, Syed Jafar Mehdi, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 10, pp. 2085-2089.e1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top